The clinical trials of the world’s first coronavirus vaccine on volunteers at Sechenov First Moscow State Medical University have been successfully completed. Chief researcher Elena Smolyarchuk, who heads the Center for Clinical Research on Medications at Sechenov University, told Russian news agency TASS on Sunday that the human trials for the vaccine have been completed at the university and they will be discharged soon.
On Thursday 16 July, Russia was believed to be accused hacker by US, UK and Canada to steal valuable intellectual private information about the vaccine research as the pandemic surges across the world.
The hacking group is supposed to be name as APT29 also known has cozy bear has attacking pharmaceutical institution involved in the making of vaccines, Also in 2016 during the presidential election the same group of hackers were implicated to hack the Democratic email accounts.
“We may say one thing; Russia has nothing to do with those attempts.” Peskov said.
The first vaccine, in the form of a solution for intramuscular administration, was carried out at the Burdenko Military Hospital. The second vaccine, in the form of a powder for the preparation of a solution for intramuscular administration, was carried out at Sechenov First Moscow State Medical University.
There are at least 21 vaccines currently under key trials, according to the World Health. The overall number of global COVID-19 cases was nearing 13.7 million, while the deaths have increased to more than 564,000, according to Johns Hopkins University in the US.